Posted in | News | Laser | LEDs

BluGlass Demonstrates World-First RPCVD Tunnel Junction Laser Diode

Australian semiconductor developer BluGlass Limited has successfully demonstrated working tunnel junction laser diodes in a world-first proof-of-concept using its proprietary remote plasma chemical vapour deposition (RPCVD) technology.

A BluGlass RPCVD semiconductor wafer manufacturing platform, the BLG-300. Image Credit: BluGlass Limited

The novel laser diode prototypes leverage BluGlass’ unique RPCVD tunnel junction technology, developed over many years for use in highpower products including laser diodes and high-brightness LEDs.

Designed to enable higher power and more efficient lasers for use in commercial applications such as 3D printing and industrial welding, these RPCVD tunnel junction laser diode prototypes have demonstrated good lasing behaviour. This milestone helps confirm the potential of the RPCVD laser diode designs to address the critical performance requirements for high value gallium nitride (GaN) laser diode applications.

GaN laser diode applications in the industry are currently limited by optical and resistive loss in the magnesiumcontaining layers (the p-type layers) which leads to low conversion efficiencies, typically in the 40-45% range compared to the close to 90% in GaN-based LEDs. Almost 50% of the power  consumed when operating GaN laser diodes is lost in the form of heat due to the highly resistive p-type layers, traditionally needed to create the electrical circuit in a laser diode.

BluGlass’ novel approach, enabled by the unique benefits of low temperature, low hydrogen RPCVD growth can eliminate the need for these highly resistive and performance losing p-type layers. RPCVD enabled novel designs replace the p-type cladding layer with an RPCVD tunnel junction and second n-type cladding layer - called a dual n-wave laser diode, paving the way to significantly improve laser diode performance in the future.

The Company will continue to optimise its RPCVD tunnel junction laser diode design, epitaxy and fabrication to maximise laser performance.

BluGlass Executive Chair James Walker said “This is an important validation of the potential of our unique RPCVD and tunnel junction technologies. This achievement is a testament to the efforts of our leading-edge team in developing a range of innovative laser diode products, including this world-first demonstration of dual-n-wave lasers. This has the potential to transform how laser diodes are made to help bring GaN lasers into a new era. “While these novel lasers have significant development required before the launch of future RPCVD enhanced products; our significantly further advanced standard (MOCVD) laser diode product development continues to focus on solving reliability and improving our downstream production ahead of launching commercial products to waiting customers.”

This announcement has been approved for release by the board.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BluGlass. (2021, August 10). BluGlass Demonstrates World-First RPCVD Tunnel Junction Laser Diode. AZoOptics. Retrieved on November 22, 2024 from https://www.azooptics.com/News.aspx?newsID=26939.

  • MLA

    BluGlass. "BluGlass Demonstrates World-First RPCVD Tunnel Junction Laser Diode". AZoOptics. 22 November 2024. <https://www.azooptics.com/News.aspx?newsID=26939>.

  • Chicago

    BluGlass. "BluGlass Demonstrates World-First RPCVD Tunnel Junction Laser Diode". AZoOptics. https://www.azooptics.com/News.aspx?newsID=26939. (accessed November 22, 2024).

  • Harvard

    BluGlass. 2021. BluGlass Demonstrates World-First RPCVD Tunnel Junction Laser Diode. AZoOptics, viewed 22 November 2024, https://www.azooptics.com/News.aspx?newsID=26939.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.